Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis

Hengbo Zhou(University of Colorado Anschutz Medical Campus), Heide L. Ford(University of Colorado Denver), Lesley A. Mathews Griner(National Center for Advancing Translational Sciences), Matthew D. Galbraith(Rome Foundation), Dominique Ramirez(Colorado State University), Michael Oliphant(University of Colorado Anschutz Medical Campus), Daniel P. Regan(University of Colorado Cancer Center), James C. Costello(University of Colorado Cancer Center), Noel Southall(National Center for Advancing Translational Sciences), Andrew Goodspeed(University of Colorado Cancer Center), Melanie A. Blevins(University of Colorado Anschutz Medical Campus), Rachel Culp‐Hill(University of Colorado Denver), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Jessica Y. Hsu(University of Colorado Anschutz Medical Campus), Samarjit Patnaik(National Center for Advancing Translational Sciences), Juan Marugán, Elena Barnaeva(National Center for Advancing Translational Sciences), Jennyvette Trinidad-Pineiro(University of Colorado Anschutz Medical Campus), Daniel L. Gustafson(Colorado State University), Rebecca King(National Center for Advancing Translational Sciences), Rui Zhao(University of Colorado Anschutz Medical Campus), Xin Hu(Discovery Institute), Marc Ferrer(National Institutes of Health), Lingdi Zhang(University of Colorado Denver), Deguang Kong(University of Colorado Anschutz Medical Campus)

Cancer Research

April 27, 2020

Cited by 47

|Journal of Mammary Gland Biology and Neoplasia|2010|972

|Critical Reviews in Biochemistry and Molecular Biology|2013|791

|JCI Insight|2020|600

|Nature Medicine|2016|570

|Cancer Cell|2018|565

Related Papers